Geert O. Janssens

Mianyong Ding, Maximilian Knoll, Semi Harrabi et al.

Deep learning-based organs/structures-at-risk(OARs) auto-contouring models can improve radiotherapy workflows, but models trained on adult data often underperform in pediatric patients. Developing robust pediatric-specific models is hindered by data scarcity and fragmentation across centers. Federated learning (FL) enables privacy-preserving collaborative training without the need for data sharing. We evaluated the feasibility and performance of FL for developing pediatric-specific OAR segmentation models across two European medical centers. Computed tomography (CT) images from pediatric patients from Utrecht and Heidelberg with a renal tumor or abdominal neuroblastoma were retrospectively collected and locally processed. An nnU-Net-based framework segmented 19 OARs using local and FL schemes. FL was implemented with secure weight exchange on a cloud storage across institutional firewalls. Performance was assessed using the Dice similarity coefficient (DSC), 95th percentile Hausdorff distance, and mean surface distance. Robustness to patient orientation, false-positive segmentation of surgically removed kidneys, and failure cases were identified. A total of 310 postoperative CTs from 272 patients (105 renal tumors, 167 neuroblastomas) were included. Local models performed well on their respective center data but showed significantly reduced cross-center performance for four to seven of the nine evaluated OARs (DSC). In contrast, the FL model matched local performance for at least seven of nine OARs and achieved the best cross-center results across three metrics, with DSC gains of 0.003-0.007 over local models. FL also maintained stable performance across patient orientations and reduced false-positive kidney segmentations. Real-world FL improves cross-center robustness of CT-based OAR segmentation models in pediatric upper abdominal tumors.

Mianyong Ding, Matteo Maspero, Annemieke S Littooij et al.

Purposes: This study aimed to develop a computed tomography (CT)-based multi-organ segmentation model for delineating organs-at-risk (OARs) in pediatric upper abdominal tumors and evaluate its robustness across multiple datasets. Materials and methods: In-house postoperative CTs from pediatric patients with renal tumors and neuroblastoma (n=189) and a public dataset (n=189) with CTs covering thoracoabdominal regions were used. Seventeen OARs were delineated: nine by clinicians (Type 1) and eight using TotalSegmentator (Type 2). Auto-segmentation models were trained using in-house (ModelPMC-UMCU) and a combined dataset of public data (Model-Combined). Performance was assessed with Dice Similarity Coefficient (DSC), 95% Hausdorff Distance (HD95), and mean surface distance (MSD). Two clinicians rated clinical acceptability on a 5-point Likert scale across 15 patient contours. Model robustness was evaluated against sex, age, intravenous contrast, and tumor type. Results: Model-PMC-UMCU achieved mean DSC values above 0.95 for five of nine OARs, while spleen and heart ranged between 0.90 and 0.95. The stomach-bowel and pancreas exhibited DSC values below 0.90. Model-Combined demonstrated improved robustness across both datasets. Clinical evaluation revealed good usability, with both clinicians rating six of nine Type 1 OARs above four and six of eight Type 2 OARs above three. Significant performance 2 differences were only found across age groups in both datasets, specifically in the left lung and pancreas. The 0-2 age group showed the lowest performance. Conclusion: A multi-organ segmentation model was developed, showcasing enhanced robustness when trained on combined datasets. This model is suitable for various OARs and can be applied to multiple datasets in clinical settings.

M. Virgolin, Z. Wang, B. V. Balgobind et al.

To study radiotherapy-related adverse effects, detailed dose information (3D distribution) is needed for accurate dose-effect modeling. For childhood cancer survivors who underwent radiotherapy in the pre-CT era, only 2D radiographs were acquired, thus 3D dose distributions must be reconstructed from limited information. State-of-the-art methods achieve this by using 3D surrogate anatomies. These can lack personalization and lead to coarse reconstructions. We present and validate a surrogate-free dose reconstruction method based on Machine Learning (ML). Abdominal planning CTs ($n$=142) of recently-treated childhood cancer patients were gathered, their organs at risk were segmented, and 300 artificial Wilms' tumor plans were sampled automatically. Each artificial plan was automatically emulated on the 142 CTs, resulting in 42,600 3D dose distributions from which dose-volume metrics were derived. Anatomical features were extracted from digitally reconstructed radiographs simulated from the CTs to resemble historical radiographs. Further, patient and radiotherapy plan features typically available from historical treatment records were collected. An evolutionary ML algorithm was then used to link features to dose-volume metrics. Besides 5-fold cross-validation, a further evaluation was done on an independent dataset of five CTs each associated with two clinical plans. Cross-validation resulted in Mean Absolute Errors (MAEs) $\leq$0.6 Gy for organs completely inside or outside the field. For organs positioned at the edge of the field, MAEs $\leq$1.7 Gy for D$_{mean}$, $\leq$2.9 Gy for D$_{2cc}$, and $\leq$13% for V$_{5Gy}$ and V$_{10Gy}$, were obtained, without systematic bias. Similar results were found for the independent dataset. Our novel, ML-based organ dose reconstruction method is not only accurate but also efficient, as the setup of a surrogate is no longer needed.